AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Moxifloxacin in South Africa
6 products registered with SAHPRA — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| AVEBACT 400 | 41/20.1.1/0778 | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | 21 Jul 2025 |
| BAYQUIN IV | 42/20.1.1/0595 | Bayer (Pty) Ltd û Isando | active | 1 Jan 1900 |
| MOXIBAY IV | 42/20.1.1/0592 | Bayer (Pty) Ltd û Isando | active | 1 Jan 1900 |
| BAYQUIN TABLETS | 42/20.1.1/0594 | Bayer (Pty) Ltd û Isando | active | 1 Jan 1900 |
| FLOXAVE 400 | 48/20.1.1/0021 | Hetero Drugs South Africa (Pty) Ltd | active | 1 Jan 1900 |
| VIGAMOX EYE DROPS | A40/15.1/0164 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
Moxifloxacin — SAHPRA Registration Details
SAHPRA (South Africa) has 6 registered products containing Moxifloxacin, of which 5 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Moxifloxacin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.